Carlsmed Stock Faces A Crucial Week After Friday’s Drop
Carlsmed shares head into Monday’s U.S. premarket on the back foot after a sharp Friday drop, leaving investors to decide whether recent procedure-growth momentum is enough to steady the newly listed spine-surgery company. The stock closed Friday at $11.42, down 3.3% on the day and about 5.7% below the prior Friday’s close of $12.11. Market data put Carlsmed’s equity value at about $306 million; the shares remain roughly 24% below the $15 price set in its July 2025 initial public offering.